Citation: A. Borella et al., ROLE OF THE 5-HT1A RECEPTOR IN DEVELOPMENT OF THE NEONATAL RAT-BRAIN - PRELIMINARY BEHAVIORAL-STUDIES, Neuropharmacology, 36(4-5), 1997, pp. 445-450
Authors:
WHITAKERAZMITIA PM
WINGATE M
BORELLA A
GERLAI R
RODER J
AZMITIA EC
Citation: Pm. Whitakerazmitia et al., TRANSGENIC MICE OVEREXPRESSING THE NEUROTROPHIC FACTOR S-100-BETA SHOW NEURONAL CYTOSKELETAL AND BEHAVIORAL SIGNS OF ALTERED AGING PROCESSES - IMPLICATIONS FOR ALZHEIMERS-DISEASE AND DOWNS-SYNDROME, Brain research, 776(1-2), 1997, pp. 51-60
Citation: Ec. Azmitia et al., CELLULAR-LOCALIZATION OF THE 5-HT1A RECEPTOR IN PRIMATE BRAIN NEURONSAND GLIAL-CELLS, Neuropsychopharmacology, 14(1), 1996, pp. 35-46
Citation: M. Nishi et al., ENHANCED SYNAPTOPHYSIN IMMUNOREACTIVITY IN RAT HIPPOCAMPAL CULTURE BY5-HT1A AGONIST, S100B, AND CORTICOSTEROID RECEPTOR AGONISTS, Synapse, 23(1), 1996, pp. 1-9
Authors:
CLARKE C
CLARKE K
MUNEYYIRCI J
AZMITIA E
WHITAKERAZMITIA PM
Citation: C. Clarke et al., PRENATAL COCAINE DELAYS ASTROGLIAL MATURATION - IMMUNODENSITOMETRY SHOWS INCREASED MARKERS OF IMMATURITY (VIMENTIN AND GAP-43) AND DECREASED PROLIFERATION AND PRODUCTION OF THE GROWTH-FACTOR S-100, Developmental brain research, 91(2), 1996, pp. 268-273
Citation: Pm. Whitakerazmitia et al., SEROTONIN DEPLETION IN THE ADULT-RAT CAUSES LOSS OF THE DENDRITIC MARKER MAP-2 - A NEW ANIMAL-MODEL OF SCHIZOPHRENIA, Neuropsychopharmacology, 12(3), 1995, pp. 269-272
Authors:
WHITAKERAZMITIA PM
RAIO M
RAIO D
BORELLA A
Citation: Pm. Whitakerazmitia et al., A 5-HT3 RECEPTOR ANTAGONIST FAILS TO PREVENT CISPLATIN-INDUCED TOXICITY IN IMMATURE RAT SPINAL-CORD, European journal of pharmacology, 275(2), 1995, pp. 139-143
Citation: Ec. Azmitia et al., 5-HT1A AGONIST AND DEXAMETHASONE REVERSAL OF PARA-CHLOROAMPHETAMINE INDUCED LOSS OF MAP-2 AND SYNAPTOPHYSIN IMMUNOREACTIVITY IN ADULT-RAT BRAIN, Brain research, 677(2), 1995, pp. 181-192
Citation: Pm. Whitakerazmitia et Ec. Azmitia, ASTROGLIAL 5-HT1A RECEPTORS AND S-100-BETA IN DEVELOPMENT AND PLASTICITY, Perspectives on developmental neurobiology, 2(3), 1994, pp. 233-238
Citation: Pm. Whitakerazmitia et al., EFFECTS OF GESTATIONAL EXPOSURE TO MONOAMINE-OXIDASE INHIBITORS IN RATS - PRELIMINARY BEHAVIORAL AND NEUROCHEMICAL STUDIES, Neuropsychopharmacology, 11(2), 1994, pp. 125-132
Citation: K. Kramer et al., IN-VITRO RELEASE OF [H-3] 5-HYDROXYTRYPTAMINE FROM FETAL AND MATERNALBRAIN BY DRUGS OF ABUSE, Developmental brain research, 78(1), 1994, pp. 142-146
Authors:
UEDA S
GU XF
WHITAKERAZMITIA PM
NARUSE I
AZMITIA EC
Citation: S. Ueda et al., NEURO-GLIAL NEUROTROPHIC INTERACTION IN THE S-100-BETA RETARDED MUTANT MOUSE (POLYDACTYLY-NAGOYA) .1. IMMUNOCYTOCHEMICAL AND NEUROCHEMICAL STUDIES, Brain research, 633(1-2), 1994, pp. 275-283
Authors:
UEDA S
HOU XP
WHITAKERAZMITIA PM
AZMITIA EC
Citation: S. Ueda et al., NEURO-GLIAL NEUROTROPHIC INTERACTION IN THE S-100-BETA RETARDED MUTANT MOUSE (POLYDACTYLY-NAGOYA) .2. COCULTURES STUDY, Brain research, 633(1-2), 1994, pp. 284-288
Citation: Pm. Whitakerazmitia et al., LOCALIZATION OF 5-HT(1A) RECEPTORS TO ASTROGLIAL CELLS IN ADULT-RATS - IMPLICATIONS FOR NEURONAL-GLIAL INTERACTIONS AND PSYCHOACTIVE DRUG MECHANISM OF ACTION, Synapse, 14(3), 1993, pp. 201-205